Independent fund research. Built on SEC filings.

How we research funds

ETF · Leveraged & Inverse · Direxion

LABU Holdings: What Direxion Daily S&P Biotech Bull 3X ETF Owns

Ticker LABU · Index fund · · Holdings as of Jul 31, 2026

Expense ratio
0.96%$96/yr per $10k
5-yr return
−39.6%annualized
1-yr return
+78.7%as of Dec 2025
Net assets
$494.4Mall share classes
Holdings
163

Bottom line

What does LABU hold?

LABU held 163 positions as of Jul 31, 2026. Its largest holding is Dreyfus at 15.86% of the fund, and the top 10 positions add up to 64.8%. By asset type it is 26% do, 67% stocks, 36% cash & short-term funds.

Updated Sep 28, 2026

LABU top 25 holdings

#HoldingType% of fundValue
1 Dreyfus
DREYFUS GOV'T CASH MGMT -INSTITUTIONAL CUSIP 262006208…
Cash & short-term funds 15.86%$78.4M
2 Goldman Financial
GOLDMAN FINL SQ TRSRY INST 506
Cash & short-term funds 14.83%$73.3M
3 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO 9.63%$47.6M
4 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO 7.30%$36.1M
5 Goldman Sachs Liq Es Fd A
GOLDMAN SACHS FIN GOV 465 INSTITUT
Cash & short-term funds 5.35%$26.5M
6 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO 4.85%$24.0M
7 N/a
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
DO 3.87%$19.2M
8 Apogee Therapeutics Inc APGE Stocks 1.11%$5.5M
9 Oruka Therapeutics Inc ORKA Stocks 1.03%$5.1M
10 Dianthus Therapeutics Inc DNTH Stocks 0.96%$4.7M
11 Erasca Inc ERAS Stocks 0.93%$4.6M
12 Twist Bioscience Corp TWST
Twist Bioscience Corporation COM USD0.00001
Stocks 0.92%$4.6M
13 Kymera Therapeutics Inc KYMR
Kymera Therapeutics Inc COM
Stocks 0.90%$4.5M
14 Spyre Therapeutics Inc SYRE Stocks 0.89%$4.4M
15 Revolution Medicines Inc RVMD
Revolution Medicines Inc COM
Stocks 0.89%$4.4M
16 Cg Oncology Inc CGON Stocks 0.88%$4.4M
17 Protagonist Therapeutics Inc PTGX
Protagonist Therapeutics Inc COM USD0.00001
Stocks 0.88%$4.4M
18 Praxis Precision Medicines Inc PRAX UW
PRAXIS PRECISION MEDICINES I
Stocks 0.87%$4.3M
19 Regeneron Pharmaceuticals Inc REGN
Regeneron Pharmaceuticals, Inc. COM USD0.001
Stocks 0.87%$4.3M
20 Cogent Biosciences Inc COGT
Cogent Biosciences Inc. COM
Stocks 0.85%$4.2M
21 Natera Inc NTRA
Natera Incorporation COM USD0.0001
Stocks 0.84%$4.2M
22 Arrowhead Pharmaceuticals Inc ARWR
Arrowhead Pharmaceuticals Inc COM USD0.001
Stocks 0.82%$4.0M
23 Travere Therapeutics Inc TVTX
Travere Therapeutics Inc COM
Stocks 0.82%$4.0M
24 Roivant Sciences Ltd ROIV Stocks 0.81%$4.0M
25 Relay Therapeutics Inc RLAY
Relay Therapeutics Inc COM
Stocks 0.81%$4.0M

Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 28, 2026

Asset mix

DO26.3%
Stocks67.1%
Cash & short-term funds36.0%

Country exposure

BM0.8%
CA0.1%
CH0.7%
IE0.8%
KY0.1%
NL0.7%
US125.8%
VG0.4%